Browse by all authors Browse By Author Name - Scott,+H.+L.

Browse Results (30 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Scott, H. L., Pow, D. V., Tannenberg, A. E. G. and Dodd, P. R. (2002) Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. Journal of Neuroscience, 22 3: RC206: 1-5. 249   59
Hynd, M. R., Scott, H. L. and Dodd, P. R. (2002). Alzheimer's disease-related changes of the human cortical glutamate NMDA receptor: A quantitative spatio-temporal analysis of endogenous hNR1 and hNR2 mRNA levels using competitive RT-PCR in post-mortem human brain. In: 8th International Conference on Alzheimer's Disease and Related Disorders. 8th Int Conf on Alzheimer's Disease & Related Disorders, Stockholm, ((Poster)). 20-25 July, 2002. 118  
Pow, D. V., Sullivan, R., Reye, P. and Scott, H. L. (2001). An epitope of a glutamate transporter GLT-1 is differentially detected in light and dark adapted rat retina. In: G. J. Chader, Investigative Ophthalmology & Visual Science : Proceedings of the Association for Research in Vision and Ophthalmology - 2001 Annual Meeting. Annual Meeting of the ARVO, Fort Lauderdale, Florida, (S728-S728). 29/4 - 4/5 2001. 50   0
Scott, H. L. and Dodd, P. R. (1999). Characteristics of neuronal glutamate transport in Alzheimer disease. In: Society of Neuroscience Abstracts. 29th Annual Meeting of the Society of Neuroscience, Miami Beach, Florida, (2121). 23-28 October, 1999. 32  
Scott, H. L., Kuo, S. and Dodd, P. R. (2000). Characterization of neuronal glutamate transport in rat and human brain tissue in relation to Alzheimer disease pathogenesis. In: 20th Annual Meeting, Australian Neuroscience Society, Melbourne Convention Centre, Melbourne, (132-132). 30 January-2 February, 2000. 45  
Scott, H. L., Dodd, P. R. and Pow, D. A. (2001). Ectopic expression of glial glutamate transporters in cerebral cortex in control and Alzheimer's disease cases. In: Proceedings of the Australian Neuroscience Society. Australian Neuroscience Society 21st Annual Meeting, Brisbane, (87-87). 28-31 January, 2001. 38  
Scott, H. L., Dodd, P. R. and Pow, D. V. (2001). Ectopic expression of glial glutamate transporters in cerebral cortex in control and Alzheimer's disease cases. In: P.Pilowsky, Proceedings of the Australian Neuroscience Society. 21st Meeting of the Australian Neuroscience Society, Brisbane, (87-87). 28-31 January 2001. 53  
Tannenberg, R. K., Scott, H. L. and Dodd, P. R. (2001). Evidence of intact nerve terminals in Alzheimer disease. In: Proceedings of the Australian Neuroscience Society. Australian Neuroscience Society 21st Annual Meeting, Brisbane, (127-127). 28-31 Jan, 2001. 57  
Williams, S. M., Sullivan, R. K. P., Scott, H. L., Finkelstein, D. I., Colditz, P. B., Lingwood, B. E., Dodd, P. R. and Pow, D. V. (2005) Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia, 49 4: 520-541. doi:10.1002/glia.20139 71   67 Cited 72 times in Scopus72 0
Hynd, M. R., Scott, H. L. and Dodd, P. R. (2001) Glutamate(NMDA) receptor NR1 subunit mRNA expression in Alzheimer's disease. Journal of Neurochemistry, 78 1: 175-182. doi:10.1046/j.1471-4159.2001.00409.x 72   35 Cited 34 times in Scopus34 0
Hynd, M. R., Dodd, P. R. and Scott, H. L. (2003). GlutamateNMDA receptor subunit variants in Alzheimer disease. In: The Society for Neuroscience 33rd Annual Meeting. Society for Neuroscience 33rd Annual Meeting, New Orleans, (Abstract). 8-12 Nov, 2003. 30  
Gregoratos, D., Scott, H. L., Danbolt, N.C. and Dodd, P. R. (2004). Glutamate transporter protein expression in Alzheimer's disease. In: Journal of Neurochemistry. 6th Biennial Meeting of the Asian-Pacific Society for Neurochemistry (APSN), Hong Kong, (65-65). 4-7 February 2004. doi:10.1046/j.1474-1644.2003.2314p26_01.x 173   0
Dodd, P. R. and Scott, H. L. (2003). Glutamate transporters, excitotoxicity, and human neurodegenerative disease. In: 23rd Annual Meeting of the Australian Neuroscience Society. 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, (Abstract). 28-31 January, 2003. 80  
Tannenberg, R. K., Scott, H. L., Robinson, P. and Dodd, P. R. (2002). Levels of synaptophysin and dynamin in Alzheimer disease. In: Australian Neuroscience Society 22nd Annual Meeting. Australian Neuroscience Society 22nd Annual Meeting, Sydney, ((Poster)). 4-6 February, 2002. 68  
Williams, S.M., Scott, H. L., Innes, D. J., Pow, D. V. and Dodd, P. R. (2002). Localisation and genotyping of glutamate transporter EAA12 in Alzheimer's disease. In: Australian Neuroscience Society Annual Meeting. Australian Neuroscience Society Annual Meeting, Sydney, ((Poster)). 4-6 February, 2002. 47  
Williams, S. M., Scott, H. L., Innes, D. J., Pow, D. V. and Dodd, P. R. (2002). Localisation and Genotyping of Glutamate Transporter EAAT2 in Alzheimer’s Disease. In: Proc Aust Neuroscience Soc. 13. 22nd Annual Meeting of the Australian Neuroscience Society (ANS)., Sydney, (). 4-6 February. 17  
Liyou, N. E., Buller, K. M., Tresillian, M. J., Elvin, C. M., Scott, H. L., Dodd, P. R., Tannenberg, A. E. G. and McManus, M. E. (2003) Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: An immunohistochemical study. Journal of Histochemistry and Cytochemistry, 51 12: 1655-1664. 78   30 Cited 31 times in Scopus31
Hynd, M. R., Scott, H. L. and Dodd, P. R. (2002). MRNA quantitation of alternatively spliced NMDA receptor NR1 isoforms by competitive RT-PCR in human brain. In: Australian Neuroscience Society 22nd Annual Meeting. Australian Neuroscience Society 22nd Annual Meeting, Sydney, ((Poster)). 4-6 February, 2002. 47  
Tannenberg, R. K., Scott, H. L., Pow, D. V. and Dodd, P. R. (1999). Neuronal loss and implication of excitotoxicity in Alzheimer's disease. In: Proceedings of the Australian Neuroscience Society. 19th Annual Meeting of the Australian Neuroscience Society, Hobart Convention Cen., Hobart, (217). 31 Jan - 3 Feb, 1999. 46  
Hynd, M. R., Scott, H. L. and Dodd, P. R. (2003). NMDA receptor dysfunction in Alzheimer's disease. In: Proceedings of the International Society for Neurochemistry. Meeting of the International Society for Neurochemistry, Kyoto, Japan, (50-50). August, 2003. doi:10.1046/j.1474-1644.2003.2314p21_01.x 133   0
Hynd, M. R., Dodd, P. R. and Scott, H. L. (2004). NMDA receptor dysfunction in Alzheimer's disease. In: Journal of Neurochemistry. 6th Biennial Meeting of Asian-Pacific Society for Neurochemistry, Hong Kong, (50-50). 4-7 Feb, 2004. doi:10.1046/j.1474-1644.2003.2314p21_01.x 92   0
Scott, H. L. and Dodd, P. R. (2000). Pharmacological characterization of neuronal glutamate transport in Alzheimer's disease. In: 7th International Conference on Alzheimer's Disease and Related Disorders. , Washington Hilton & Towers, Washington, (S10). 9-13 July, 2000. 52  
Hynd, M. R., Scott, H. L. and Dodd, P. R. (2003) Quantitation of alternatively spliced NMDA receptor NR1 isoform mRNA transcripts in human brain by competitive RT-PCR. Brain Research. Protocols, 11 1: 52-66. doi:10.1016/S1385-299X(03)00015-1 72   6 Cited 7 times in Scopus7 0
Tannenberg, R. K., Scott, H. L. and Dodd, P. R. (2004). Regional variance of synaptic protein levels in Alzheimer disease. In: Journal of Neurochemistry. 6th Biennial Meeting of Asian-Pacific Society for Neurochemistry, Hong Kong, (20-21). 4th - 7th February, 2004. 47  
Williams, S.M., Innes, D. J., Scott, H. L., Pow, D. V. and Dodd, P. R. (2002). The glutamate transporter EAAT2 and Alzheimer disease. In: ISBRA and RSA Joint Meeting. ISBRA and RSA Joint Meeting, San Francisco, ((Abstract)). 3 June 2002. 59  
Williams, S. M., Innes, D. J., Scott, H. L., Pow, D. V. and Dodd, P. R. (2002). The Glutamate Transporter EAAT2 and Alzheimer’s Disease. In: Australian and New Zealand Society for Neuropathology (ANZSNP)., Sydney, (). 2-3 June 2002. 18  
Tannenberg, R. K., Scott, H. L., Westphalen, R. I. and Dodd, P. R. (2004) The identification and characterization of excitotoxic nerve-endings in Alzheimer disease. Current Alzheimer Research, 1 1: 11-25. 82   Cited 20 times in Scopus20
Tannenberg, R. K., Hynd, M. R., Scott, H. L. and Dodd, P. R. (2004). The quantitation of pre- and postsynaptic proteins in Alzheimer’s disease and effect of apolipoprotein E genotype. In: Society for Neuroscience Abstracts. Neuroscience 2004, San Diego, California, (). 23-27 October, 2004. 78  
Gregoratos, D., Dodd, P. R. and Scott, H. L. (2002). The use of competitive RT/PCR to examine glutamate transporter gene expression in Alzheimer's disease. In: 8th International Conference on Alzheimer's Disease and Related Disorders. 8th Int Conf on Alzheimer's Disease and Related Disorders, Stockholm, ((Poster)). 20-25 July, 2002. 64  
Westphalen, R. I., Dodd, P. R. and Scott, H. L. (2001). Vesicular glutamate transport is selectively reduced in temporal cortex in Alzheimer disease. In: Proceedings of the Australian Neuroscience Society. Proceedings of the Aust Neuroscience Society Australian Neuroscience Society 21st Annual Meeting, Brisbane, (90-90). 28-31 January, 2001. 52